Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors

Local iron homeostasis in the breast ductal carcinoma microenvironment

(2016) Oriana Marques et al.   BMC CANCER

Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression

(2016) Christina Mertens et al.   PLoS One

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome

(2016) G. Marziali et al.   Scientific Reports

Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone

(2015) Chiara Maura Ciniselli et al.   Expert Review of Proteomics

Targeting cancer by binding iron: Dissecting cellular signaling pathways

(2015) Goldie Y.L. Lui et al.   Oncotarget

Iron homeostasis and anemia markers in early breast cancer

(2014) Pierre-Jean Lamy et al.   CLINICA CHIMICA ACTA

Stratification of clear cell renal cell carcinoma by signaling pathway analysis

(2014) Mattia Cremona et al.   Expert Review of Proteomics

Identification of erythroferrone as an erythroid regulator of iron metabolism

(2014) Léon Kautz et al.   NATURE GENETICS

Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities

(2014) Caiguo Zhang et al.   Protein & Cell

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer

(2013) R. Orlandi et al.   ANNALS OF ONCOLOGY

Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2

(2013) Eva Maurer et al.   BIOCHEMICAL JOURNAL

The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis

(2013) Ahmed A. Alkhateeb et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IRP2 Regulates Breast Tumor Growth

(2013) Wei Wang et al.   CANCER RESEARCH

Iron and Diabetes Risk

(2013) Judith A. Simcox et al.   Cell Metabolism

Methylation signature of lymph node metastases in breast cancer patients

(2012) Zeinab Barekati et al.   BMC CANCER

Adipocyte iron regulates adiponectin and insulin sensitivity

(2012) J. Scott Gabrielsen et al.   JOURNAL OF CLINICAL INVESTIGATION

Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study

(2011) Pascal Jézéquel et al.   INTERNATIONAL JOURNAL OF CANCER

Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure

(2011) Amy R. Peck et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting cancer metabolism: a therapeutic window opens

(2011) Matthew G. Vander Heiden   NATURE REVIEWS DRUG DISCOVERY

Role of ferritin alterations in human breast cancer cells

(2010) Svitlana I. Shpyleva et al.   BREAST CANCER RESEARCH AND TREATMENT

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

(2009) Hany Onsy Habashy et al.   BREAST CANCER RESEARCH AND TREATMENT

Synthetic and natural iron chelators: therapeutic potential and clinical use

(2009) Heather C Hatcher et al.   Future Medicinal Chemistry

Role of hypoxia in the hallmarks of human cancer

(2009) Kai Ruan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

(2009) Billy Andriopoulos Jr et al.   NATURE GENETICS

Iron Sequestration and Anemia of Inflammation

(2009) Tomas Ganz et al.   SEMINARS IN HEMATOLOGY